Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands
- 14 October 2004
- journal article
- other
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 18 (12), 2032-2035
- https://doi.org/10.1038/sj.leu.2403538
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Should Adolescents With Acute Lymphoblastic Leukemia Be Treated as Old Children or Young Adults? Comparison of the French FRALLE-93 and LALA-94 TrialsJournal of Clinical Oncology, 2003
- Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer GroupBlood, 2003
- Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01Blood, 2001
- Six Months of Maintenance Chemotherapy After Intensified Treatment for Acute Lymphoblastic Leukemia of ChildhoodJournal of Clinical Oncology, 2000
- Outcome of Treatment in Children with Philadelphia Chromosome–Positive Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 2000
- Duration and intensity of maintenance chemotherapy in acute lymphoblastic leukaemia: overview of 42 trials involving 12 000 randomised childrenThe Lancet, 1996
- 6-Mercaptopurine Cumulative Dose: A Critical Factor of Maintenance Therapy in Average Risk Childhood Acute Lymphoblastic LeukemiaPediatric Hematology and Oncology, 1994
- High‐dose methotrexate improves clinical outcome in children with acute lymphoblastic leukemia: St. Jude total therapy study XMedical and Pediatric Oncology, 1988